Literature DB >> 22594506

Program in pharmacogenomics at the Ohio State University Medical Center.

Joseph P Kitzmiller, Peter J Embi, Kandamurugu Manickam, Kevin M Sweet, Mitch A Phelps, Rebecca D Jackson, Clay B Marsh, Wolfgang Sadee.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22594506      PMCID： PMC3650730          DOI： 10.2217/pgs.12.46

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  11 in total

1.  Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

Authors:  L V Sequist; R S Heist; A T Shaw; P Fidias; R Rosovsky; J S Temel; I T Lennes; S Digumarthy; B A Waltman; E Bast; S Tammireddy; L Morrissey; A Muzikansky; S B Goldberg; J Gainor; C L Channick; J C Wain; H Gaissert; D M Donahue; A Muniappan; C Wright; H Willers; D J Mathisen; N C Choi; J Baselga; T J Lynch; L W Ellisen; M Mino-Kenudson; M Lanuti; D R Borger; A J Iafrate; J A Engelman; D Dias-Santagata
Journal:  Ann Oncol       Date:  2011-11-09       Impact factor: 32.976

2.  The mystery of missing heritability: Genetic interactions create phantom heritability.

Authors:  Or Zuk; Eliana Hechter; Shamil R Sunyaev; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-05       Impact factor: 11.205

3.  Foundational biomedical informatics research in the clinical and translational science era: a call to action.

Authors:  Philip R O Payne; Peter J Embi; Joyce Niland
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

4.  Clinical research informatics: challenges, opportunities and definition for an emerging domain.

Authors:  Peter J Embi; Philip R O Payne
Journal:  J Am Med Inform Assoc       Date:  2009-03-04       Impact factor: 4.497

Review 5.  Translational informatics: enabling high-throughput research paradigms.

Authors:  Philip R O Payne; Peter J Embi; Chandan K Sen
Journal:  Physiol Genomics       Date:  2009-09-08       Impact factor: 3.107

6.  The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients.

Authors:  Laure Elens; Rachida Bouamar; Dennis A Hesselink; Vincent Haufroid; Teun van Gelder; Ron H N van Schaik
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

7.  Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.

Authors:  D Wang; Y Guo; S A Wrighton; G E Cooke; W Sadee
Journal:  Pharmacogenomics J       Date:  2010-04-13       Impact factor: 3.550

8.  Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients.

Authors:  Laure Elens; Ron H van Schaik; Nadtha Panin; Martine de Meyer; Pierre Wallemacq; Dominique Lison; Michel Mourad; Vincent Haufroid
Journal:  Pharmacogenomics       Date:  2011-09-08       Impact factor: 2.533

9.  A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.

Authors:  Laure Elens; Rachida Bouamar; Dennis A Hesselink; Vincent Haufroid; Ilse P van der Heiden; Teun van Gelder; Ron H N van Schaik
Journal:  Clin Chem       Date:  2011-09-08       Impact factor: 8.327

Review 10.  Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.

Authors:  Joseph P Kitzmiller; David K Groen; Mitch A Phelps; Wolfgang Sadee
Journal:  Cleve Clin J Med       Date:  2011-04       Impact factor: 2.321
View more
  3 in total

1.  Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional.

Authors:  Amy Curry Sturm; Kevin Sweet; Kandamurugu Manickam
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

2.  Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine.

Authors:  G Farrugia; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2013-03-11       Impact factor: 6.875

3.  Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review.

Authors:  John H McDermott; Stuart Wright; Videha Sharma; William G Newman; Katherine Payne; Paul Wilson
Journal:  Front Med (Lausanne)       Date:  2022-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.